Readers and Tweeters Feel Americans’ Pain
KHN gives readers a chance to comment on a recent batch of stories.
Health Industry
1,401-1,420 of 4,016 results
-
-
Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?
Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.
-
At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’
Billings Clinic in Montana is past the tipping point as it looks for places to add intensive care unit beds and is on the cusp of rationing care to deal with the surge of sick covid patients in a state with significant anti-vaccination sentiment.
By Nick Ehli -
Congress Cites KHN Investigation in Probe of National Academies
The House oversight committee is requesting conflict-of-interest disclosure forms from a National Academies committee studying organ transplants. KHN previously reported on apparent conflicts among members of a committee studying drug waste.
By Christina Jewett and JoNel Aleccia -
Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment
Patients with advanced cancer and heart disease are among those who have had to have surgeries and other treatments delayed and rescheduled as a high number of critically ill, unvaccinated covid patients strain the medical system.
-
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
-
Under Pressure, Montana Hospital Considers Adding Psych Beds Amid a Shortage
A hospital in Bozeman, Montana, is considering whether to add inpatient psychiatric care after a concerted push from mental health advocates. But even if it adds beds, hospitals across Montana provide a cautionary tale: finding enough workers to staff such beds is its own challenge, and some behavioral health units routinely reach capacity.
-
Journalists Explain Ramifications of Theranos Trial and Texas’ New Abortion Law
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Florida Spine Surgeon and Device Company Owner Charged in Kickback Scheme
Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.
By Fred Schulte -
Lack of a Vaccine Mandate Becomes Competitive Advantage in Hospital Staffing Wars
After months of burnout from the pandemic, hospitals are scrambling to fill nursing and other jobs. Some administrators, particularly in rural areas, are afraid to implement vaccine mandates that alienate their short-handed staffs.
By Lauren Weber -
Jaw Surgery Takes a $27,119 Bite out of One Man’s Budget
A Seattle patient discovers the hard way that you can still hit a lifetime limit for certain types of care. And health plans can vary a lot from one job to the next, even if the insurer is the same.
-
KHN’s ‘What the Health?’: Vaccine Approval Moves the Needle on Covid
The FDA’s formal approval of the first vaccine to prevent covid-19 may or may not prompt doubters to go out and get shots, but it has clearly prompted employers to make vaccination a work requirement. Meanwhile, moderates and liberals in the U.S. House put aside their differences long enough to keep a giant social-spending bill on track, at least for now. Joanne Kenen of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.
-
Microbiome Startups Promise to Improve Your Gut Health, but Is the Science Solid?
A raft of startups are charging consumers hundreds of dollars to analyze the microbes in their gut and offer dietary advice based on the results. But scientists say scant research has been done, and as customers of one company have learned the hard way, the experience isn’t always smooth.
-
Mission and Money Clash in Nonprofit Hospitals’ Venture Capital Ambitions
Nonprofit hospitals of all sizes have been trying their luck as venture capitalists, saying their investments improve care through the creation of new medical devices, health software and other innovations. But the gamble at times has been harder to pull off than expected.
By Jordan Rau -
‘An Arm and a Leg’: Meet the Mississippi Lawyer Who Helped Start the Fight for Charity Care
The man famous for taking on Big Tobacco in the '90s, and winning, launched a series of ill-fated national lawsuits against nonprofit hospitals. This episode is the first in a series looking at the origins of charity care.
-
KHN’s ‘What the Health?’: Booster Time
As the delta variant continues to spread around the U.S., the Biden administration is taking steps to authorize covid vaccine boosters, require nursing home workers to be vaccinated and protect school officials who want to require masks despite state laws banning those mandates. Meanwhile, the U.S. House is returning from its summer break early to start work on its giant budget bill, which includes a long list of health policy changes. Alice Miranda Ollstein of Politico, Margot Sanger-Katz of The New York Times and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more.
-
Apple Aims to Push More Patient Data to Doctors. But Who Can Gauge Its Impact on Health?
The Silicon Valley giant has been cryptic about its plan for the growing mound of health data available through its iPhones and watches. Health systems have experimented with the company’s health app, but it hasn’t yet become central to treatment.
By Sarah Kwon -
Surgeons Cash In on Stakes in Private Medical Device Companies
Doctors tied to professional sports teams share in investment bonanza.
By Fred Schulte -
Injuries Mount as Sales Reps for Device Makers Cozy Up to Surgeons, Even in Operating Rooms
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients, including former Olympian Mary Lou Retton.
By Fred Schulte -
Hard Lessons From a City That Tried to Privatize Public Health
Facing bankruptcy, Detroit largely dismantled its public health department in 2012, and the city essentially went two years without a government-run public health system. Five years later, this major American city offers a grim cautionary tale.